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ABSTRACT: Diabetes and malaria are prevalent diseases in the tropics. In spite of the availability of various independent therapies 
for each of these diseases, treatments of patients with both diseases have been quite challenging. Mormodiaca charantia is used in 
Nigeria separately to treat malaria and diabetes. This present study was aimed at investigating the effects of the methanolic 
extract of Mormodiaca charantia leaves (100 mg/kg body weight) on diabetic mice infected with malaria. Animals were infected 
with malaria and induced with diabetes by intraperitoneal injection of 1 x 107 Plasmodium berghei and 100 mg/kg body weight 
alloxan monohydrate respectively. Animal subjects were treated with 5 mg/kg body weight of chloroquine phosphate, 10mg/kg 
body weight of glibenclamide and 100 mg/kg body weight of the extract daily for five days. Parasitemia, packed cell volume (PCV) 
and blood glucose level were monitored in the course of the treatment: Antioxidant status, kidney function test and histology of 
the kidney and pancreas section were examined. There was a decrease in the parasitemia level with a concomitant increase in the 
PCV, heamoglobin (Hb) and red blood cell count (RBC) level in groups treated with M. charantia and chloroquine. Blood glucose 
of all the treated groups decreased significantly (p<0.05) at the end of the experiment. The creatinine, uric acid and urea values in 
the group treated with the plant extract was significantly increased with values 1.23 mg/dl, 2.68 mg/dl and 30.15 mg/dl 
respectively, however, the group treated with both standard drugs had the highest urea value (51.55 mg/dl). Photomicrograph of 
the section of the pancreas and kidney of the infected group showed treated with 100 mg/kg of the plant extract showed mild 
degeneration of the islet of langerhan  and mild atropy of the glomeruli respectively. These results support further studies on the 
use of Mormodiaca charantia as a single treatment for both diseases. 
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INTRODUCTION 
Malaria is a vector-borne infectious disease caused by 
protozoan parasites (genus plasmodium) widespread in the tropical 
and subtropical regions including parts of the America, Asia and 
Africa. Each year, there are approximately 5.5 million cases of 
malaria, causing the death of about one to three million people, the 
majority of whom are under 5 year-old and pregnant women 
(Lothar et al., 2008; Dapper et al., 2007; Murnigsih et al., 2005). Four 
species of plasmodium are infectious to humans and these include 
Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and 
Plasmodium ovale. Plasmodium falciparum is responsible for the vast 
majority of deaths from malaria (Lothar et al., 2008). This is mainly 
due to the two major complications; cerebral malaria and anaemia 
(Lothar et al., 2008; Mohapatra, 2001). Other symptoms include 
fever, chills, nausea and flu-like illness. Spleenomegaly, severe 
headache, hepatomegaly, hemoglobinuria with renal failure may 
occur (Trampuz et al., 2003). Severe malaria can progress extremely 
rapidly and cause coma or even death within hours or days 
(Trampuz et al., 2003).  
Diabetes is a disease characterized by abnormally high blood 
glucose and the excretion of excess glucose in the urine (Ghosh et 
al., 2004). Diabetes is subdivided on clinical grounds into Insulin 
dependent and non-insulin dependent diabetes milletus i.e IDDM 
and NIDDM or Type-1 and Type-2 respectively (Elased et al., 1995). 
NIDDM is characterized by hyperglycemia in both the fed and 
fasted state, variable degrees of hyperinsulinemia and obesity 
(Elased et al., 1995). Treatment of patients with malaria and diabete 
mellitus has been challenging (Mohapatra, 2001). This is because 
treatment with quinine dihydrochloride (one of the commonest 
antimalarial drugs) has been reported to result in hypoglycaemia 
(Mohapatra, 2001). White et al. (1983) posited that quinine 
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stimulates the release of insulin, which consequently results in 
hypoglycaemia. Hence treatment of malaria infected diabetic 
patients undergoing insulin therapy with quinine would hold 
grievous physiological implications.  Mohapatra (2001) reported 
that the treatment of such cases is so challenging because of the 
effect of the parasites and antimalarials particularly quinine on 
glucose homeostasis. 
To the best of our knowlege, there is limited information in the 
literature on the interaction of malaria with diabetes. One of such 
report is that of  Shalev et al. (1992) who reported hypoglycaemia in 
a diabetic patient infected with P. Falciparum. It has been reported 
that of the severe manifestations of occurrence of malaria and 
diabetes mellitus, cerebral malaria is the commonest form 
encountered, followed by multi organ dysfunction (Mohapatra, 
2001). In a metabolic disease like diabetes mellitus, functional 
impairment of organs like kidney and heart are frequently found 
due to vascular involvement, thus Plasmodium falciparum aggravates 
the organ dysfunction by interfering with microcirculation. This 
may probably be the explanation for the higher incidence of 
cerebral and multiple organ involvement in diabetes mellitus with 
malaria (Mohapatra, 2001). 
Increasing problems of occurrence of both diabetes and malaria 
in some patients calls for the need to explore the therapeutic 
potential of some local herbs that have been reportedly used 
separately for the treatment of diabetes mellitus and malaria, so as 
to investigate their efficacy in suitation of occurrence of both  
malaria and diabetes mellitus. One of such plant is Mormodica 
charantia (Bitter melon or balsam pear); a tropical vegetable, widely 
cultivated in Asia, Africa and South America, and has been used 
extensively in folk medicine as remedy for diabetes (Girron et al., 
1991), constipation, malaria and as antibiotics (Day et al., 1990). It is 
therefore of interest to investigate the therapeutic potential of 
Mormodiaca charantia in occurrence of malaria and diabetes mellitus 
and to study the effects of treatment on the functionality of some 
organs. Elased et al. (1995) reported slow multiplication of the 
malaria parasite in diabetes induced mice, a report which is in 
concordance with the findings of Mohapatra, (2001).  
One of the major complications of malaria infection is 
hypoglycaemia (WHO, 1990). An unexplained hypoglycaemia 
caused by P. falciparum malaria has been reported in Diabetes 
mellitus patients even before the initiation of quinine therapy 
(Jikki and Krishnamurrty, 1997; Mohapatra, 2001; Shalev et al., 
1992), likewise Elased et al. (1995) reported that the induction of 
malaria parasite or an extract of the parasite to a mouse model of 
NIDDM dramatically lowers the blood glucose level and resulted in 
reduced voluntary food intake, with consequent weight loss. 
Taylor et al. (1992) reported that injection of parasite supernatant 
caused a significant hypoglycaemia in normal mice. Infection of 
mice with blood-stage Plasmodium yoelii and P. chabaudi malaria 
induced hypoglycaemia in normal mice and normalized the 
hyperglycaemia of mice made moderately diabetic with 
streptozotocin (Elased et al., 1995). It has also been shown that 
hypoglycaemia during infection with P. Yoelii and P. chabaudi was 
associated with hyperinsulinaemia, only occurring with 
parasitaemia above 50% (Elased et al., 1995), although there was 
recovery when the parasitemia fell in the control group while in the 
diabetic mice, the blood glucose again fell to normal values. It was 
noted that the drop was greatest in the mice with the highest 
parasitaemia (Elased et al., 1995).  
Although this plant has been used separately for the treatment 
of diabetes and malaria, there is no documented study of its use in 
treating together both diabetes and malaria, this study was 
designed to explore the antiplasmodial and antidiabetic potentials 
of Mormodiaca charantia on combined infection of malaria and 
diabetes mellitus. 
MATERIALS AND METHODS 
Chemicals 
Methanol used was product of Eagle Scientific Limited, 
Nottingham. Giemsa stain was obtained from Eagle Anosantec 
Laboratories, UK. Immersion oil was obtained from Panzonar 
Laboratories supplies, Button road, Canada. Chloroquine 
diphosphate salt was obtained from Sigma Chemical Company, St. 
Louis, Mo USA. Other reagents used were of analytical grade and 
were prepared using distilled water. 
Animals 
Adult male mice, 4-6 weeks old, weighing between 20 + 2 g 
obtained from Nigerian Institute of Medical Research (NIMR) 
Lagos was used for the study. The mice were housed in plastic 
cages and maintained under standard laboratory conditions with 
free access to rat pellets and tap water ad-libitum (NH publication 
#65-23, revised in 1985). 
Parasites 
A chloroquine-sensitive strain of Plasmodium bergei (NK-65) was 
obtained from the Nigerian Institute of Medical Research (NIMR) 
Yaba, Lagos state. 
Plant material and extract preparation 
Fresh leaves of Mormodiaca charantia was harvested from a farm 
in Obantoko area of Abeokuta Ogun state and autenticated at the 
Department of Forestry and Wildlife of the University. The extract 
of the plant was prepared according to a method of Adewole et.al., 
(2011). Fresh leaves of the plant were dried in the shade at room 
temperature and pulvrised to powder using an electric blender. 200 
g of the powdered plant was percolated in 1 L of absolute methanol 
for 72 hours after which it was filtered. The filtrate was poured 
into a beaker and allowed to evaporate at room temperature to 
yield the extract concentrate, the percentage yield was 4.6% w/w.  
Phytochemical screening 
The powedered sample of Mormodiaca charantia leaves was 
tested for the presence of secondarymetabolites such as alkaloids, 
flavanoids, phenolics and steroids following the methods described 
by Trease and Evans (1978). 
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Experimental Design 
Animals were randomly divided into 6 groups of eight mice 
each. Animals in group 1 were not innoculated with the parasite 
nor induced with diabetes, while the other groups innoculated 
from the same donor mouse and also induced with diabetes. The 
percentage parasitemia and the red blood cell count was first 
determined and appropriate dilutions of the infected blood with 
isotonic saline was done. Each mouse in the infected groups was 
innoculated on day 0 intraperitoneally with 0.2 ml of infected 
blood containing about 1 x 107 P. Berghei parasitized red blood cells. 
Treatment was witheld for 5 days to allow for establishment of 
infection after which hyperglycemia was induced in the mice by 
intraperitoneal injection of 100mg/kg body weight of alloxan 
monohydrate. Treatment commenced when both conditions was 
established. Parasitemia was established by screening for malaria 
parasites in tail blood of infected animals after fixing in methanol 
and staining with Giemsa stain (Ryles and Peters, 1970), likewise 
glucose level was monitored by cutting the tail tip of a conscious 
mouse and using Blood glucose on call plus strip inserted in the 
glucometer (code 131, LOT390028). 
Aqueous preparations of the extract corresponding to 100 
mg/kg body weight, an optimum dose arrived at from studies of 
dose-dependent evaluation of hyperglycemia using 100 mg/kg, 200 
mg/kg and 300mg/kg of the extract, chloroquine (corresponding to 
5 mg/kg body weight) and glibenclamide (corresponding to 10 
mg/kg body weight) were made before administering orally to the 
mice. The administration of the different treatment which lasted 
for five days is as follows: 
Group 1 (uninfected and non-induced mice): received an 
appropriate volume of sterile distilled water corresponding to the 
highest volume of extract administered. 
Group 2 (infected and induced mice): received an appropriate 
volume of sterile distilled water. 
Group 3 (infected and induced mice): received the aqueous 
preparation of the extract (100 mg/kg body weight daily). 
Group 4 (infected and induced mice): received the aqueous 
solution of chloroquine (5 mg/kg body weight daily). 
Group 5 (infected and induced mice): received the aqueous 
solution of glibenclamide (10 mg/kg body weight daily). 
Group 6 (infected and induced mice): received the aqueous 
solutions of chloroquine (5 mg/kg body weight) and glibenclamide 
(10 mg/kg body weight) daily. 
Sample colletion and analyses  
Daily blood films were made from tail blood of all the infected 
animals (Groups 2, 3, 4, 5 and 6), the percentage parasitemia and 
blood glucose level obtained through microscopic determination 
and glucometer. Percentage chemosuppression was calculated by 
subtracting the average percentage parasitemia in the treated 
group from the average percentage parasitemia in the control group 
and the value obtained was expressed as a percentage of the 
average parasitemia in the control group. Animals were sacrificed 
under slight diethyl ether anesthesia.  
Heamatological evaluation was done using the automated 
heamatological analyzer SYSMEX Corporation, Japan) wherein the 
red blood cell count (RBC), packed cell volume (PCV) 
heamoglobin concentration (Hb), mean corpuscular volume 
(MCV) were determined. The concentration of plasma urea was 
determined according to Fawcett and Scott (1960) whereas plasma 
creatinine and uric acid were determined spectrophotometrically 
as described respectively by Kaplan (1996) and Fosseti et al. (1980). 
Oxidative stress was evaluated by determining the total 
antioxidant potential (TAP), the total peroxide potential and the 
oxidative stress index was calculated using the method described 
by Harma et al., (2003). Photomicograph of the histology of the 
pancreas and kidney sections of the animals were also evaluated. 
Statistical Analysis 
Values are expressed as Mean + Standard Error Mean. The data 
were statistically analyzed using analysis of variance (ANOVA) 
and Duncan Multiple Range test (Mahajan, 1997). Data from the 
test groups were compared with their respective controls and 
differences at p<0.05 were considered to be significant. 
RESULTS 
Some of the phytochemicals present in the methanolic extract 
of M. charantia leaves are shown in Table 1. Table 2 shows the mean 
percentage parasitemia of infected mice before and during 
treatment. Parasitemia counts in the group treated with 100mg/kg 
body weight showed significant reduction (p<0.05) from 18.25% on 
day 2 to 7.42% on day 6 indicating 59.3% decrease within three 
days. Group MDQ treated with chloroquine also showed 
significant reduction (p<0.05) from 9.44% to 3.43% on day 6 
indicating over 60% reduction while group MDB showed a 
reduction of 59.4% in parasitemia level within the same period of 
time. Group MDG treated with a standard antidiabetic drug 
glibenclamide revealed significant increase (p<0.05) in parasitemia 
from 11.98% to 23.31%. 
TABLE 1 Pytochemicals of the methanolic extract of 
Mormodiaca charantia leaves 













Each of the values was a mean of  triplicate determinations + 
standard deviation. 
Blood glucose level 
  Table 3 shows variations in blood glucose level of the animals 
during the experiment. The mean blood glucose level of the mice 
ranged from 62 mg/dl in group MDG to 70.66 mg/dl in group NC 
prior to induction with diabetes using a single dose of 100 mg/kg of 
alloxan monohydrate. Blood glucose during this period was within 
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TABLE 2 Effect of treatment on the parasitemia level of the groups induced with P. berghei.  
 
TABLE 3 Effect of treatment on blood glucose level in the different groups.  
 





Day 1 Day 2 Day 3 Day 4 Day 5 D O S 
MDC 6.55+0.62a 5.83+0.26a 5.31+0.60a 7.64+0.66ab 10.19+1.33ab 14.4+2.68bc 19.79+6.62b 
MDP 
12.25+3.9b 13.83+3.0b 18.25+2.93b 15.17+2.45bc 12.50+4.49ab 9.61+3.65ab 7.42+1.95a 
MDQ 9.44+1.16b 8.29+1.26a 7.22+1.46a 5.91+1.62a 4.96+0.51a 4.26+0.45a 3.43+0.36a 
MDG 
11.98+4.41b 13.07+4.50ab 14.72+4.88ab 16.55+4.39c 18.60+3.84b 21.49+3.56cd 23.31+3.51b 
MDB 6.99+0.92a 8.32+1.18a 7.88+1.39a 5.53+0.74a 5.44+0.78a 4.77+0.69a 3.29+0.42a 
Values are mean±S.E.M. n=4 
Values within a column having different superscripts are significantly different at p<0.05 
DOS- day of sacrifice 
GRP BEFORE CONFIRM DAY2 DAY3 DAY4 DAY5 DAY6 
 






















268.00+6.08b  226.66+4.33bc 176.00+7.93c 131.66+7.69d 100.66+3.76b 
MDB 68.33+1.45a 301.66+7.88b 270.66+13.91bc 217.66+6.57bc 156.66+8.83bc 111.33+10.48cd 90.66+11.57ab 
Values are mean±S.E.M. n=4 
Values within a column having different superscripts are significantly different at p<0.05 
Group Creatinine (mg/dl) Uric acid (mg/dl) Urea (mg/dl) 
 
NC 0.79+0.07a 2.05+0.10ab 7.05+0.51a 
MDC 0.54+0.03a 1.28+0.17ab 24.63+2.16b 
MDP 1.23+0.09ab 2.68+0.29bc 30.15+8.46b 
MDQ 0.47+0.11a 1.33+0.17ab 29.90+1.85b 
MDG 0.57+0.12a 0.78+0.12a 26.75+4.69b 
MDB 0.98+0.30ab 1.35+0.35ab 51.55+10.40c 
PO 1.21+1.08ab 3.87+1.23c 13.10+1.59a 
Values are mean±S.E.M. n=4; Values within a column having different superscripts are 
significantly different at p<0.05 
NC- Normal control, MDC- Malaria diabetic control, MDP- Malaria diabetic treated 
100mg/kg body weight of methanolic extraction of M.charantia, MDQ- Malaria diabetic 
co- infected treated with 5mg/kg body weight of Chloroquine phosphate, MDG- Malaria 
diabetic co- infected treated with 10mg/kg body weight of glibenclamide, MDB- Malaria 
diabetic co- infected treated with 10mg/kg body weight of glibenclamide and 5mg/kg body 
weight of Chloroquine phosphate 
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normal range for all the animals. All groups induced with 
hyperglycemia (MDC, MDP, MDQ MDG and MDB) had about 
three to four fold  increase in their mean glucose values having 
values between 270 mg/dl and 301 mg/dl which confirmed them as 
being diabetic. 
MDC had its mean glucose level decreased from 270 mg/dl to 
211.67 mg/dl (21.85%) on day 6. MDB had the highest percentage 
decrease in mean glucose level (70.10%). The group treated with 
the plant extract MDP had decreased mean glucose values 
indicating a percentage decrease of 69.72%. There was significant 
difference (p<0.05) in blood glucose value of the treated groups 
compared to the control group. The group treated with a standard 
antidiabetic drug glibenclamide had a decrease from 287.00 mg/dl 
to 100.66 mg/dl indicating a percentage decrease of 65.15% after the 
5 days of treatment while group MDQ recorded a mean blood 
glucose reduction from 275.00 mg/dl to 199 mg/dl indicating a 27% 
decrease although the value was not significanly different at p>0.05 
from the control group (MDC). 
Kidney function test 
Table 4 shows the values of some biochemical parameters 
indicating the kidney function test. The normal control group had 
a value of 0.79 mg/dl. MDP treated with the plant extract had 
increased creatinine value of 1.23 mg/dl which was significantly 
different (p<0.05) from the normal control group. MDQ and MDG 
groups treated with the standard drugs chloroquine and 
glibenclamide had reduced creatinine having values of  0.47 mg/dl 
and 0.57 mg/dl respectively although not significantly different 
(p>0.05) when compared with MDC and NC. 
The uric acid value was significantly (p<0.05) reduced in group 
MDG having a value of 0.78mg/dl when compared to other groups. 
The group treated with the plant extract had increased uric acid 
concentration; other treated group was also reduced. 
All the infected groups had elevated urea concentration. About 
seven-fold increase was observed in group MDB when compared to 
the normal control group. All the treated groups had increased 
mean urea values, ranging from 26.75 mg/dl to 51.55 mg/dl and 
these were significantly different (p<0.05) compared to the normal 
control group (NC). 
 Heamatological parameters 
  Table 5 shows the effects of treatment on the heamatological 
parameters. It was observed that on day two of treatment, all 
groups infected with P.berghei had a significantly decreased PCV 
values (ranging from 16.60% to 25.67%) compared to the normal 
control group with a mean PCV value of 45.40%. The malaria-
infected control group (MDC) had the least PCV value among all 
the groups. The treated groups MDQ, MDB and MDP had their 
mean PCV values increased with MDQ having the highest 
percentage increase of about 46.75%. 
The Hb level of the of the infected control group MDC was 
significantly (p<0.05) reduced. MDQ had the highest Hb which 
was comparable to NC. The groups treated with 5 mg/kg 
chloroquine (MDQ and MDB) had their RBC levels increased 
compared to the other treated groups. The MCH of all the groups 
was not significantly (p>0.05) changed from NC. The MCHC of all 
the different groups was not significantly different (p>0.05) except 
for group MDC which increased when compared to NC (p<0.05). 
Likewise the MCV of all the groups except MDC was not 
significantly different from the NC. 
Oxidative stress 
Figure 1 shows the mean plot of the total peroxidation 
potential (TPP) and oxidative stress index (OSI) of the different 
groups in the course of the experiment. MDC had the highest level 
of TPP and OSI while NC had the least values for both parameters. 
The group treated with the plant extract MDP had TPP lower than 
the groups treated with both standard drug (MDQ, MDG and 
MDB). Figure 2 shows the different levels of the mean total 
antioxidant potential (TAP) of the different groups during the 
course of the experiment. MDQ had a lowered TAP while the 
group treated with both standard drugs (MDB) had TAP which 
was more than othe treated groups. 
Histological studies 
 The Pancreas 
Result of the histological studies on the pancreas of treated and 
untreated malaria-infected and diabetic-induced mice are 
presented in plates 1-4. Photomicrograph of a section of the 
pancreas of normal control mice showed normal arrangement of 
the islets of langerhans of various sizes scattered throughout the 
exocrine tissue (Plate 1). The pancreatic acinic and duct system 
appeared normal. Photomicrograph also reveals normal 
arrangement of the glandular acinni. The result showed no 
observable histological defect in the pancreas of the control mice.  
Histological observations of the pancreas of the malaria-
induced diabetic control mice (MDC) showed focal areas of 
marked degeneration of the islet of langerhans and the presence of 
intestitial oedema (Plate 2), this was also observed in infected 
group treated with chloroquine (MDQ) as seen in plate 4, in which 
the intestitial oedema was severe. There was no visual changes in 
the pancreas of the co-infected group treated with the plant 
extract as can be seen in plate 3 in which the degenerative changes 
was markedly reduced.  
Kidney 
Histopathological defects observed in the photomicrographs of 
kidney sections of treated and untreated mice are presented in 
Plates 5 to 8. Histological studies on the kidney of normal control 
mice revealed no visible lesion as the renal corpuscles appeared 
normal in dense rounded structures (Plate 5). Photomicrograph 
from kidney of mice in the positive control group (MDC) showed 
dilation of tubules as seen in plate 6. Atropy of the glomerulus and 
dilation of the Bowman capsule was observed in the histology 
section of the kidney of the malaria-infected and diabetic-induced 
mice treated with the plant extract (MDP). Plate 8 showed severe 
dilation of the tubules in the malaria-infected and diabetic-induced 
mice treated with both standard drugs (MDB). 
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TABLE 5 Effects of treatment on the Heamatological parameters.  
 
  
Group PCV-Day 2 PCV-Day 4 PCV-Day 6      Hb     RBC   MCH    MCHC    MCV 
NC 45.40+1.88d 45.55+2.04e 51.25+0.63e 19.12+1.17de 9.15+0.51e 20.97+1.15a 0.37+0.02ab 5.68+0.33ab 
MDC 16.60+3.75ab 12.17+1.73a 10.25+0.85a 5.72+0.96 a 2.77+0.37a 20.48+1.00a 0.45+0.05b 4.66+0.34a 
MDP 23.75+2.81abc 23.77+3.41bc 30.75+5.72c 12.45+2.56bc 5.35+1.42bc 27.50+6.18a 0.39+0.03ab 6.40+0.97 ab 
MDQ 25.67+8.02abc 31.20+3.93d 46.75+0.25e 18.67+0.75de 7.42+0.23de 25.16+0.77a 0.39+0.02ab 6.36+0.19 ab 
MDG 24.45+2.08ab
c 
19.32+0.78ab 20.00+0.91b 7.72+0.39a 3.80+0.35ab 20.68+1.48a 0.37+0.01ab 5.52+0.43 ab 
MDB 18.35+3.93ab 22.52+3.65bc 33.25+1.79d 15.75+0.73cd 7.15+0.39de 22.41+2.39a 0.39+0.01ab 5.61+0.58 ab 
Values are mean±S.E.M. n=4; Values within a column having different supercripts are significantly different at p<0.05 
NC- Normal control, MDC- Malaria diabetic control, MDP- Malaria diabetic treated 100mg/kg body weight of methanolic extraction 
of M.charantia, MDQ- Malaria diabetic co- infected treated with 5mg/kg body weight of Chloroquine phosphate, MDG- Malaria 
diabetic co- infected treated with 10mg/kg body weight of glibenclamide, MDB- Malaria diabetic co- infected treated with 10mg/kg 
body weight of glibenclamide and 5mg/kg body weight of Chloroquine phosphate 
FIGURE 1 Effect of treatment on the total plasma 
peroxide (TPP) in µmolH2O2/L and oxidative stress index 
(%). NC- Normal control, MDC- Malaria diabetic control, 
MDP- Malaria diabetic treated 100mg/kg body weight of 
methanolic extraction of M.charantia, MDQ- Malaria 
diabetic co- infected treated with 5mg/kg body weight of 
Chloroquine phosphate, MDG- Malaria diabetic co- 
infected treated with 10mg/kg body weight of 
glibenclamide, MDB- Malaria diabetic co- infected 
treated with 10mg/kg body weight of glibenclamide and 
5mg/kg body weight of Chloroquine phosphate 
.  
 
FIGURE 2 Effect of treatment on the Total antioxidant 
potential (TAP) in µmol.Trolox eqiuv/L. NC- Normal 
control, MDC- Malaria diabetic control, MDP- Malaria 
diabetic treated 100mg/kg body weight of methanolic 
extraction of M.charantia, MDQ- Malaria diabetic co- 
infected treated with 5mg/kg body weight of 
Chloroquine phosphate, MDG- Malaria diabetic co- 
infected treated with 10mg/kg body weight of 
glibenclamide, MDB- Malaria diabetic co- infected 
treated with 10mg/kg body weight of glibenclamide and 
5mg/kg body weight of Chloroquine phosphate 
.  
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DISCUSSION 
Prevalence of type 2 diabetes has been reported to be on 
increase worldwide (1998; Ghosh et al., 2004; Biyani et al., 2003). 
Although hypoglycemic agents, dietary fiber and low glycemic 
index foods are widely available, the public continues to maintain a 
substantial interest in dietary adjuncts that possess hypoglycemic 
properties. Over 1000 herbal products have been used by various 
cultures to lower blood glucose and treat diabetes. Among them, 
Momordiaca charantia (family Cucurbitaceae), commonly known 
as ku gua, karela, bitttergourd or bitter melon) is a popular herbal 
resource ( Marles and Farnsworth, 1995; Ethan et al., 2003). 
Malaria caused by P. falciparum is a common and life-
threatening disease responsible for over one million deaths 
annually (WHO, 2008). Presently, malaria is still the most 
dangerous parasitic infectious disease causing millions of death 
annually (Inga et al., 2002). In many countries where malaria is 
endemic the traditional medical methods hold a strong part in the 
public health care system. For safety reasons phytochemical, 
pharmacological and biochemical investigations on medicinal 
plants traditionally used as antimalarials are urgently needed (Inga 
et al., 2002). 
Although M. charantia has been known for its hypoglycemic 
effect (Giron et al., 1991; Abascal and Yarnell 2005), its 
antiplasmodial effects had been reported by Munoz et al. (2000), 
and Inga et al. (2002), while Singh et al. (2006) demonstrated its 
larvicidal activity. M.charantia has been used separately in the 
treatment of diabetes and malaria infection; there has not been any 
literature report to the best of our knowledge that reported its use 
in treating co-occurrence of both diabetes and malaria. In this 
study, we investigated some biochemical and histological changes 
that could be associated with treatment of malaria and diabetes 
mellitus in mice using extract of Mormodiaca charantia. 
The geometric increase in blood glucose concentrations 
observed in all mice after a single intraperitoneal injection of 
alloxan monohydrate confirmed the induction of insulin-
dependent diabetes mellitus (IDDM) in the mice. Earlier works by 
Nimenibo-Uadia (2003) and Ghosh et al. (2004) revealed multiple 
increases in blood glucose concentration after a single injection of 
alloxan monohydrate. This increase has been attributed to the 
toxic effect of alloxan on the beta cells of the pancreas in which 
alloxan and the product of its reduction; dialuric acid established a 
redox cycle with the formation of superoxide radicals.  These 
radicals undergo dismutation to hydrogen peroxide and reactive 
oxygen species with a simultaneously massive increase in cytosolic 
calcium concentration that ultimately causes rapid destrution of 
the beta cells. This destruction results in the inability of the 
pancreas to synthesize and secrete adequate amount of insulin 
necessary for the metabolism of carbohydrate. All treated mice 
responded positively to treatment with the plant extract and the 
standard antidiabetic drug, glibenclamide. During the course of 
treatment, marked reduction in blood glucose concentration was 
recorded for all treated animals. Blood glucose level in the positive 
control group was reduced after the experiment (about 22%), 
probably due to the parasite. Reports have shown that Plasmodium 
parasite causes hypoglycemia in experimental mice (Elased et al., 
1995; Mohapatra, 2001; Shalev et al., 1991; Taylor et al., 1992) and 
resulted in reduced voluntary food intake, with consequent weight 
loss. The group treated with the plant extract, MDP had their 
glucose levels reduced more than the group treated with the 
antidiabetic standard drug, glibenclamide. This better performance 
recorded by M. charantia may be due to a hypoglycemic 
polypeptide (polypeptide-P) of molecular weight of approximately 
11,000 (166 amino acid residues) and a glycoalkaloid (vicine), 
which have been characterized from the fruits, seeds and leaves of 
the plant  (Raman and Lau, 1996).  
Malaria infection was established in the mice by a single 
intraperitoneal injection of 0.2ml of 1 X 107 parasitized red blood 
cells from donor mice of the same strain. Parasitemia was 
established in the mice when their tail blood was viewed under the 
microscope five days after induction. All treated groups had their 
parasitemia level decreased significantly (p<0.05). Group treated 
with chloroquine had their parasitemia decreased well above 50% 
while the treated with the extract had decrease in parasitemia with 
about 50%. It was observed that the parasitemia in the positive 
control group increased all through the course of the experiment. 
Parasitemia of the groups treated with chloroquine started 
decreasing after the first day of treatment while the plant extract 
started reducing the parasitemia between the third and fourth day 
of treatment. Although, there has not been a mechanism of action 
to the best of our knowledge, however, it has been reported that 
the fraction of M. charantia that had antimalarial effect contained 
flavones, alkaloids and phenolic that could be responsible for the 
observed antimalarial activity.  
Five days after induction with P. Berghei, parasitemia was 
established in the animals after which they were made diabetic by 
a single intraperitoneal injection of alloxan monohydrate, the mean 
weight recorded for all animal groups was observed to reduce (data 
not shown). This could be as a result of low food and water intake 
that was observed in the infected groups. Other reasons for these 
observed low body weight may be due to the destructive effect of 
the injected alloxan monohydrate. Kliber et al. (1996) reported 
specific necrosis of the pancreatic islets which was also observed in 
the photomicrograph of the pancreas in this study. Histological 
examination showed necrosis of the pancreatic acini in all groups 
that were made hyperglyceamic using alloxan monohydrate. Also, 
malaria causes loss of apetite and this could also account for the 
weight loss in the different groups. The normal control group (NC) 
had a consistent increase in weight while the reverse was the case 
for the positive control group MDC.  
Kidneys maintain optimum chemical composition of the body 
fluids by acidification of urine and removal of metabolite wastes as 
urea, uric acid, creatinine and ions (Biyani et al., 2003). During 
renal disease, the concentrations of these metabolites increase in 
blood. Increase in urea level has been observed in acute and chronic 
renal disease (Biyani et al., 2003). There was high level of urea in 
the malaria-infected and diabetic-induced groups in this study. 
Geoffrey (2006) reported that creatinine level can be either normal 
or high during renal diseases. Results showed that the group 
treated with plant extract had an increased creatinine value of 1.23 
mg/dl. Photomicrogram of the kidney tissue of the malaria-infected  








PLATE 1 Pancreas section showing normal appearance of 
the pancreatic acini (PA) and islet of langerhans(IL) in 
the pancreas of the normal control group (x 300) E & H.  
 
PLATE 2 Pancreas section showing marked degeneration of 
the pancreatic islets (IL) and interstitial oedema (IE)  in 




PLATE 3 Pancreas section of a mild degeneration of the islet 
of langerhan (IL) in the pancreas of the coinfected group 
treated with 100mg/kg of the methanolic extract of 
M.charantia (x 300) H & E. 
PLATE 4 Pancreas section of severe interstitial oedema (IO) 
and marked degeneration of the islet of langerhan (MIL) in 
the pancreas of coinfected group treated with 5mg/kg of 







PLATE 5 Section of the normal control group showing  
normal appearance of the glomerulus (G), tissues and blood 
vessels (B) of the kidney (x 300) E & H. 
PLATE 6 Section of the kidney of the positive co-infected 
group showing dilation of the tubules (T) and luminar 
containig protein cast (P) (x 300) E & H. 
PLATE 7 Section of the infected group treated with the plant 
extract kidney showing mild atropy (A) of the glomeruli and 
dilation (D) of the Bowman space (x 300) H & E  
PLATE 8 Section of the co-infected group treated with 
both standard drugs showing severe dilation (SD) of 
the tubules in the glomeruli. (x 300) H & E. 
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and diabetic-induced mice revealed dilation of the bowman 
capsule. This could be linked to increased body fluids and 
metabolites observed. 
 Packed cell volume (PCV) which is a measure of the relative 
mass of cells present in a sample of blood was observed to increase 
in all the groups that were treated as observed on the day that the 
animals were sacrificed. This observation of anemic state has been 
reported in Plasmodium infected mice that were untreated (Iyawe 
and Onigbinde, 2009; Adam et al., 2005; Akpotuzor et al., 2007). 
Anaemia, a condition characterized by decrease in total cell mass of 
the blood, it is a state in which the blood index values of total 
haemoglobin is <12g/dl (Uthman, 1994). Result obtained from this 
study showed that all the groups infected with malaria were 
anaemic, although there was increase in the Hb level with 
treatment especially with the groups treated with the plant 
extract; this therefore suggests the haemopoetic properties of the 
extract used. Most diabetic patients suffer from oxidative stress 
probably as a result of increased pro-oxidant and lowered 
antioxidant concentration. In our study, MDC had the highest 
total peroxidation potential and oxidative stress index. This could 
be as a result of the increased level of pro oxidants produced in the 
pancreas as reported by Bansal et al. (1980). 
CONCLUSION 
Result obtained from the study revealed the antiplasmodial 
and hypoglycemic potentials of  Mormodiaca charantia for the 
treatment of malaria and diabetes mellitus. Results of physiological 
and biochemical analysis observed in this study have also suggest 
that treatment with the plant extract might not induce negative 
side effects on organ funtions at the tested dosages. 
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